Enanta Pharmaceuticals Inc trades by members of Congress

Purchases and sales of Enanta Pharmaceuticals Inc shares that members of the House have disclosed since January 3, 2015, with the value range each one reported and a link to the original filing.

Purchases, last 12 months 0 trades None disclosed

Sales, last 12 months 0 trades None disclosed

Members trading, last 12 months 0 3 purchases and sales since January 3, 2015

Enanta Pharmaceuticals Inc trades disclosed by members of Congress
				Report
Daniel S. Goldman House · D-NY 10	Sale (full)$1,001 - $15,000	Aug 13, 2023	Jul 12, 2023	Filing for ENTA on Jul 12, 2023
Thomas MacArthur House · NJ	Sale (full)$1,001 - $15,000 · Joint	Jun 7, 2015	May 27, 2015	Filing for ENTA on May 27, 2015
Thomas MacArthur House · NJ	Purchase$1,001 - $15,000 · Joint	Apr 11, 2015	Mar 20, 2015	Filing for ENTA on Mar 20, 2015

Source: periodic transaction reports filed with the Clerk of the House of Representatives under the STOCK Act (Senate reports are not included yet). Members report trades by themselves, their spouses and dependent children. Amounts are the value ranges as filed, not exact figures, and a report can be filed up to 45 days after the trade, so the latest trades may not appear yet. Scanned paper reports are linked but not transcribed. By law (5 U.S.C. §13107) these reports may not be used for any commercial purpose other than by news and communications media for dissemination to the general public; we publish them free, as news.

← Back to Enanta Pharmaceuticals Inc · Insider trading · Funds · All trades by members of Congress